Prognyx oncology intelligence

Live ClinicalTrials.gov oncology trial comparison around an asset, plus landscapes and CI briefings.

我该使用它吗

质量与安全性

A
描述质量
100%
模式完整度
97%
命名质量
93%
投毒风险
100%
权限匹配度
100%
协议合规性
100%

基于对工具定义和协议合规性的自动分析。

上下文开销

~568token 数(工具定义)
~951 B典型响应大小
对注意力的影响极小(占 128k 上下文窗口的 0.44%)

这是每次将服务器的工具加载到模型上下文窗口时所消耗的大致 token 数。数值越高,可用于其他任务的注意力就越少。

安装

一键安装

将以下内容添加到你的 `claude_desktop_config.json` 文件中:

{
  "mcpServers": {
    "oncology-intelligence": {
      "url": "https://www.prognyx.com/api/mcp"
    }
  }
}

远程端点

https://www.prognyx.com/api/mcpstreamable-http

它能做什么

工具清单

工具(3)

🟢 只读🟡 写入🔴 删除⚪ 未知
🟢compare_trials(asset, indication)

Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.

输入模式

{
  "type": "object",
  "properties": {
    "asset": {
      "type": "string",
      "maxLength": 80,
      "description": "Public asset or target, e.g. \"sotorasib\", \"KRAS G12C\", \"B7-H3\"."
    },
    "indication": {
      "type": "string",
      "maxLength": 80,
      "description": "Oncology indication, e.g. \"colorectal cancer\", \"NSCLC\"."
    }
  },
  "required": [
    "asset",
    "indication"
  ],
  "additionalProperties": false
}
🟢search_registry(query, limit)

Live landscape for a target, asset, company, indication or NCT number: total and active study counts, leading sponsors, phase mix, the most recently updated studies with URLs, and related Prognyx briefings. Counts for phases and sponsors come from a recent sample, stated in the result.

输入模式

{
  "type": "object",
  "properties": {
    "query": {
      "type": "string",
      "maxLength": 160,
      "description": "e.g. \"KRAS G12C\", \"Nuvalent\", \"claudin 18.2 gastric cancer\", \"NCT05132075\"."
    },
    "limit": {
      "type": "integer",
      "minimum": 1,
      "maximum": 25,
      "default": 10,
      "description": "Studies to return."
    }
  },
  "required": [
    "query"
  ],
  "additionalProperties": false
}
🟢search_briefings(query, limit)

Prognyx oncology competitive-intelligence briefings (each claim linked to a primary source) matching a drug, company, target or indication, newest first, with URL, date and summary.

输入模式

{
  "type": "object",
  "properties": {
    "query": {
      "type": "string",
      "maxLength": 120,
      "description": "Drug, company, target or indication. Empty returns the latest."
    },
    "limit": {
      "type": "integer",
      "minimum": 1,
      "maximum": 20,
      "default": 5,
      "description": "Briefings to return."
    }
  },
  "additionalProperties": false
}

社区

评价此服务器

证据

最近观测

已验证未记录版本3 个工具